BHF Kleinwort Benson Group’s Bristol-Myers Squibb BMY Stock Holding History

BHF Kleinwort Benson Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-117,256	Closed	-$7.8M	–	354
2015 Q2	$7.8M	Sell	117,256 -476	-0.4%	-$31.4K	0.26%	107
2015 Q1	$7.59M	Sell	117,732 -84,739	-42%	-$5.3M	0.21%	123
2014 Q4	$12M	Sell	202,471 -202,096	-50%	-$11.4M	0.31%	104
2014 Q3	$20.7M	Buy	404,567 +22,059	+6%	+$1.1M	0.68%	41
2014 Q2	$18.6M	Sell	382,508 -9,214	-2%	-$454K	0.55%	55
2014 Q1	$20.4M	Buy	391,722 +247,491	+172%	+$13.2M	0.59%	58
2013 Q4	$7.67M	Buy	144,231 +132,725	+1,154%	+$6.76M	0.49%	74
2013 Q3	$532K	Buy	11,506 +8,948	+350%	+$393K	0.07%	148
2013 Q2	$105K	Buy	+2,558	New	+$111K	0.01%	206

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BHF Kleinwort Benson Group's BMY Position: Q3 2015 in Review

BHF Kleinwort Benson Group sold out of Bristol-Myers Squibb (BMY) in Q3 2015, closing a stake of 117,256 shares — an estimated $7.8M sold.

BHF Kleinwort Benson Group first reported a position in BMY in Q2 2013 and held it in 9 quarters. The position peaked at $20.7M in Q3 2014. 1,453 funds tracked by Wall St. Rank hold BMY as of Q3 2015.

BHF Kleinwort Benson Group reported no remaining Bristol-Myers Squibb position as of Q3 2015 after selling out during the quarter.
BHF Kleinwort Benson Group sold 117,256 Bristol-Myers Squibb shares in Q3 2015, an estimated $7.8M.
BHF Kleinwort Benson Group first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 9 quarters.
BHF Kleinwort Benson Group's Bristol-Myers Squibb position peaked at $20.7M in Q3 2014.
1,453 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.

Based on BHF Kleinwort Benson Group's 13F filing for Q3 2015, filed 13 Nov 2015.